Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) Normalized Income after Taxes data is not available for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Normalized Income after Taxes |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$10.74B |
|
$3.03B |
|
$4.70B |
|
$15.43B |
|
$2.47B |
|
-- |
|
$189.40M |
|
$2.66B |
|
$12.77B |
|
$12.40B |
|
$12.77B |
|
3.29B |
|
| Cash Flow Statement Financials | |
$1.57B |
|
$-227.11M |
|
$-1.58B |
|
$2.69B |
|
$2.46B |
|
$-227.83M |
|
-- |
|
$-1.52B |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|